X

Articles

22Apr

Update on CTS Implementation of the Grifols Procleix Ultrio Elite Assay

0 Comments | | Return |

In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.

 

Click here for all the details: Communications

Related

New Online Learning Center with New Content

The new online Learning Center with new content can still be found under the “Training” folder on ...

Read More >

CTS moving to new sFTP Server

CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...

Read More >

Special Testing Laboratory Test Result Reporting Change

An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...

Read More >

FDA Updates Emergency Use Authorization for COVID-19 Convalescent Plasma

On December 28, 2021, the FDA updated the emergency use authorization  (EUA) for COVID-19 conva...

Read More >

FDA Releases Zika Virus (ZIKV) Guidance and Grifols ZIKV Assay Licensed

On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...

Read More >

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- 1st Update

This is the first update to the original CTS communication distributed on July 6th. As previously co...

Read More >

Subscribe here to receive CTS updates!

Name